IBM Watson Health Extends Partnership With U.S. to Help Vets With Cancer

IBM Watson Health will continue to collaborate with the U.S. Department of Veterans Affairs on the development of treatment regimens for veterans with cancer through next June. IBM Watson Health has announced an extension through June 2019 of its collaboration with the U.S. Department of Veterans Affairs (VA) to help treat veterans with cancer using artificial intelligence (AI). The partners use the Watson cognitive computing platform to inform the delivery of personalized treatment plans by the VA's oncologists. This requires researchers and clinicians to sequence patients' DNA to locate likely cancer-causing mutations and determine strategies to target those mutations. AI can help oncologists interpret genomic data faster and with less difficulty.